Adamantane, min.99%, pour la synthèse, 100 g, emballage en verre

Ethyl 2-(1,3,2-dioxaborinan-2-yl)benzoate, 96%, 1g

ETHYL 7-AMINOQUINOLINE-2-CARBOXYLATE, 95.0%, 1g

Colonne capillaire GC ROTI®Cap-1, 10 m, 0,53 mm, 1,00 µm, 1 pièce(s)

4,4,5,5-Tetramethyl-2-(4-(phenoxymethyl)phenyl)-1,3,2-dioxaborolane, 98+%, 1g

8-Bromo-6-chloro-2-methylimidazo[1,2-b]pyridazine, 95.0%, 100mg

1-Octyl-1H-imidazole, 95.0%, 10g

(4R,6R)-tert-Butyl-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxane-4-acetate, 97.0%, 500g

3-(2-Thienyl)propionic acid, 95.0%, 100g

1,3-Dimethyl-6-nitro-1H-indazole, 98%, 1g

1-(4-Fluorophenyl)-4-methyl-1H-pyrazol-5-amine, 1g

(S)-2-((tert-Butoxycarbonyl)amino)-3-cyclopentylpropanoic acid, 95.0%, 1g

4,4-Diphenylbutan-2-one, 95+%, 1g